Thank you for signing up to the Anaphylaxis UK Business Newsletter! Keep an eye on your inbox each month for the need-to-know updates for your business.
The National Institute for Health and Care Excellence (NICE) has released its final draft guidance recommending Itulazax® (Betula verrucosa)—the first sublingual (under the tongue) tablet immunotherapy, which could help up to 27,000 people in England with moderate to severe birch
[…]
Going on holiday is all about relaxing but for people with serious allergies, dining out in unfamiliar locations can bring added stress.
[…]
The UK medicines regulator (MHRA) has approved EURneffy®, the country’s first needle-free adrenaline nasal spray for the emergency treatment of serious allergic reactions (anaphylaxis) in adults and children weighing 30kg or more. This new option is expected to become available
[…]